First monkeys, and then us? Human cloning must stay off limits
By Marcy Darnovsky,
New Scientist
| 01. 24. 2018
Remember the human cloning controversies of the early 2000s? One reason they faded was that scientists were unable to clone non-human primates. Now that researchers have produced two cloned monkeys, we should brace ourselves for a rerun of arguments in favour of human clones. But human reproductive cloning would be every bit as misguided and dangerous now as it was then.
As long ago as 1971, James Watson of double helix fame warned in The Atlantic about the prospect of “Moving Toward the Clonal Man”. He later changed his mind and began promoting human reproductive cloning, as well as suggesting that human germline modification could tackle stupidity and ensure all women are “pretty”.
In 1997, headlines announced that scientists in the UK had created what had long been considered biologically impossible: a cloned mammal, a sheep dubbed “Dolly”. Debate about creating human clones immediately followed. Time, for example, put Dolly on its cover the following month and posed the question: “Will There Ever Be Another You?”
A few mavericks claimed to be on the verge...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...